-
2
-
-
79957509557
-
Atrial fibrillation and death after myocardial infarction: A community study
-
Jabre P, Jouven X, Adnet F, Thabut G, Bielinski SJ, Weston SA et al. Atrial fibrillation and death after myocardial infarction: A community study. Circulation. 2011;123:2094-2100.
-
(2011)
Circulation
, vol.123
, pp. 2094-2100
-
-
Jabre, P.1
Jouven, X.2
Adnet, F.3
Thabut, G.4
Bielinski, S.J.5
Weston, S.A.6
-
3
-
-
65949090068
-
Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications
-
Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30:1038-1045.
-
(2009)
Eur Heart J
, vol.30
, pp. 1038-1045
-
-
Schmitt, J.1
Duray, G.2
Gersh, B.J.3
Hohnloser, S.H.4
-
4
-
-
84903304206
-
Incidence and prognostic significance of silent atrial fibrillation in acute myocardial infarction
-
Stamboul K, Zeller M, Fauchier L, Gudjoncik A, Buffet P, Garnier F et al. Incidence and prognostic significance of silent atrial fibrillation in acute myocardial infarction. Int J Cardiol. 2014;174:611-617.
-
(2014)
Int J Cardiol.
, vol.174
, pp. 611-617
-
-
Stamboul, K.1
Zeller, M.2
Fauchier, L.3
Gudjoncik, A.4
Buffet, P.5
Garnier, F.6
-
5
-
-
67649321426
-
Trends in atrial fibrillation complicating acute myocardial infarction
-
Saczynski JS, McManus D, Zhou Z, Spencer F, Yarzebski J, Lessard D et al. Trends in atrial fibrillation complicating acute myocardial infarction. Am J cardiol. 2009;104:169-174.
-
(2009)
Am J cardiol.
, vol.104
, pp. 169-174
-
-
Saczynski, J.S.1
McManus, D.2
Zhou, Z.3
Spencer, F.4
Yarzebski, J.5
Lessard, D.6
-
7
-
-
84885484473
-
Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets?
-
Rochette L, Lorin J, Zeller M, Guilland JC, Lorgis L, Cottin Y et al. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets? Pharmacol Ther. 2013;140:239-257.
-
(2013)
Pharmacol Ther
, vol.140
, pp. 239-257
-
-
Rochette, L.1
Lorin, J.2
Zeller, M.3
Guilland, J.C.4
Lorgis, L.5
Cottin, Y.6
-
8
-
-
33645501775
-
Asymmetric dimethylarginine (adma): A novel risk marker in cardiovascular medicine and beyond
-
Boger RH. Asymmetric dimethylarginine (adma): A novel risk marker in cardiovascular medicine and beyond. Ann Med. 2006;38:126-136.
-
(2006)
Ann Med
, vol.38
, pp. 126-136
-
-
Boger, R.H.1
-
9
-
-
77951642455
-
The role of asymmetric dimethylarginine (adma) in endothelial dysfunction and cardiovascular disease
-
Sibal L, Agarwal SC, Home PD, Boger RH. The role of asymmetric dimethylarginine (adma) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev. 2010;6:82-90.
-
(2010)
Curr Cardiol Rev.
, vol.6
, pp. 82-90
-
-
Sibal, L.1
Agarwal, S.C.2
Home, P.D.3
Boger, R.H.4
-
10
-
-
0031424947
-
Interference of l-arginine analogues with l-arginine transport mediated by the y+ carrier hcat-2b
-
Closs EI, Basha FZ, Habermeier A, Forstermann U. Interference of l-arginine analogues with l-arginine transport mediated by the y+ carrier hcat-2b. Nitric oxide. 1997;1:65-73.
-
(1997)
Nitric Oxide
, vol.1
, pp. 65-73
-
-
Closs, E.I.1
Basha, F.Z.2
Habermeier, A.3
Forstermann, U.4
-
11
-
-
0041357001
-
Endothelial dysfunction induced by hyperhomocyst (e) inemia: Role of asymmetric dimethylarginine
-
Stuhlinger MC, Oka RK, Graf EE, Schmolzer I, Upson BM, Kapoor O et al. Endothelial dysfunction induced by hyperhomocyst (e) inemia: Role of asymmetric dimethylarginine. Circulation. 2003;108:933-938.
-
(2003)
Circulation
, vol.108
, pp. 933-938
-
-
Stuhlinger, M.C.1
Oka, R.K.2
Graf, E.E.3
Schmolzer, I.4
Upson, B.M.5
Kapoor, O.6
-
12
-
-
1642453719
-
Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans
-
Kielstein JT, Impraim B, Simmel S, Bode-Boger SM, Tsikas D, Frolich JC et al. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation. 2004;109:172-177.
-
(2004)
Circulation
, vol.109
, pp. 172-177
-
-
Kielstein, J.T.1
Impraim, B.2
Simmel, S.3
Bode-Boger, S.M.4
Tsikas, D.5
Frolich, J.C.6
-
13
-
-
0041733065
-
Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase
-
Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol. 2003;23:1455-1459.
-
(2003)
Arterioscler Thromb Vasc Biol.
, vol.23
, pp. 1455-1459
-
-
Achan, V.1
Broadhead, M.2
Malaki, M.3
Whitley, G.4
Leiper, J.5
MacAllister, R.6
-
14
-
-
4444248826
-
Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: Involvement of renin-angiotensin system and oxidative stress
-
Suda O, Tsutsui M, Morishita T, Tasaki H, Ueno S, Nakata S et al. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: Involvement of renin-angiotensin system and oxidative stress. Arterioscler Thromb Vasc Biol. 2004;24:1682-1688.
-
(2004)
Arterioscler Thromb Vasc Biol.
, vol.24
, pp. 1682-1688
-
-
Suda, O.1
Tsutsui, M.2
Morishita, T.3
Tasaki, H.4
Ueno, S.5
Nakata, S.6
-
15
-
-
27744511357
-
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: Results from the atherogene study
-
Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: Results from the atherogene study. Circ Res. 2005;97:e53-59.
-
(2005)
Circ Res
, vol.97
, pp. e53-e59
-
-
Schnabel, R.1
Blankenberg, S.2
Lubos, E.3
Lackner, K.J.4
Rupprecht, H.J.5
Espinola-Klein, C.6
-
16
-
-
84936996921
-
Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction
-
Zeller M, Korandji C, Guilland JC, Sicard P, Vergely C, Lorgis L et al. Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction. Arterioscler Thromb Vasc Biol. 2008;28:954-960.
-
(2008)
Arterioscler Thromb Vasc Biol.
, vol.28
, pp. 954-960
-
-
Zeller, M.1
Korandji, C.2
Guilland, J.C.3
Sicard, P.4
Vergely, C.5
Lorgis, L.6
-
17
-
-
39349085786
-
Asymmetrical dimethylarginine level in atrial fibrillation
-
Cengel A, Sahinarslan A, Biberoglu G, Hasanoglu A, Tavil Y, Tulmac M et al. Asymmetrical dimethylarginine level in atrial fibrillation. Acta cardiol. 2008;63:33-37.
-
(2008)
Acta cardiol.
, vol.63
, pp. 33-37
-
-
Cengel, A.1
Sahinarslan, A.2
Biberoglu, G.3
Hasanoglu, A.4
Tavil, Y.5
Tulmac, M.6
-
18
-
-
84855831160
-
The impact of rapid atrial pacing on adma and endothelial nos
-
Goette A, Hammwohner M, Bukowska A, Scalera F, Martens-Lobenhoffer J, Dobrev D et al. The impact of rapid atrial pacing on adma and endothelial nos. Int J Cardiol. 2012;154:141-146.
-
(2012)
Int J Cardiol.
, vol.154
, pp. 141-146
-
-
Goette, A.1
Hammwohner, M.2
Bukowska, A.3
Scalera, F.4
Martens-Lobenhoffer, J.5
Dobrev, D.6
-
19
-
-
74749108725
-
Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke
-
Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, Von Holten RA et al. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Atherosclerosis. 2010;208:518-523.
-
(2010)
Atherosclerosis
, vol.208
, pp. 518-523
-
-
Schulze, F.1
Carter, A.M.2
Schwedhelm, E.3
Ajjan, R.4
Maas, R.5
Von Holten, R.A.6
-
20
-
-
84881329752
-
Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram
-
Chao TF, Lu TM, Lin YJ, Tsao HM, Chang SL, Lo LW, et al. Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram. PloS one. 2013;8:e71675.
-
(2013)
PloS One
, vol.8
, pp. e71675
-
-
Chao, T.F.1
Lu, T.M.2
Lin, Y.J.3
Tsao, H.M.4
Chang, S.L.5
Lo, L.W.6
-
21
-
-
65649142017
-
A new equation to estimate glomerular filtration rate
-
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al. A new equation to estimate glomerular filtration rate. Ann Inter Med. 2009;150:604-612.
-
(2009)
Ann Inter Med
, vol.150
, pp. 604-612
-
-
Levey, A.S.1
Stevens, L.A.2
Schmid, C.H.3
Zhang, Y.L.4
Castro, A.F.5
Feldman, H.I.6
-
22
-
-
77956458757
-
HPLC determination of plasma dimethylarginines: Method validation and preliminary clinical application
-
Ivanova M, Artusi C, Boffa GM, Zaninotto M, Plebani M. HPLC determination of plasma dimethylarginines: Method validation and preliminary clinical application. Clin Chim Acta. 2010;411:1632-1636.
-
(2010)
Clin Chim Acta
, vol.411
, pp. 1632-1636
-
-
Ivanova, M.1
Artusi, C.2
Boffa, G.M.3
Zaninotto, M.4
Plebani, M.5
-
23
-
-
84878798260
-
High levels of asymmetric dimethylarginine are strongly associated with low hdl in patients with acute myocardial infarction
-
Lorin J, Guilland JC, Korandji C, Touzery C, Bichat F, Chagnon A et al. High levels of asymmetric dimethylarginine are strongly associated with low hdl in patients with acute myocardial infarction. PloS one. 2013;8:e64796.
-
(2013)
PloS One
, vol.8
, pp. e64796
-
-
Lorin, J.1
Guilland, J.C.2
Korandji, C.3
Touzery, C.4
Bichat, F.5
Chagnon, A.6
-
24
-
-
77957699729
-
Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the european society of cardiology (ESC)
-
Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the european society of cardiology (esc). Eur Heart J. 2010;31:2369-2429.
-
(2010)
Eur Heart J
, vol.31
, pp. 2369-2429
-
-
Camm, A.J.1
Kirchhof, P.2
Lip, G.Y.3
Schotten, U.4
Savelieva, I.5
Ernst, S.6
-
25
-
-
65249184373
-
Role of symmetric dimethylarginine in vascular damage by increasing ros via store-operated calcium influx in monocytes
-
Schepers E, Glorieux G, Dhondt A, Leybaert L, Vanholder R. Role of symmetric dimethylarginine in vascular damage by increasing ros via store-operated calcium influx in monocytes. Nephrol Dial Transplant. 2009;24:1429-1435.
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 1429-1435
-
-
Schepers, E.1
Glorieux, G.2
Dhondt, A.3
Leybaert, L.4
Vanholder, R.5
-
26
-
-
79955623424
-
The role of asymmetric and symmetric dimethylarginines in renal disease
-
Schwedhelm E, Boger RH. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol. 2011;7:275-285.
-
(2011)
Nat Rev Nephrol.
, vol.7
, pp. 275-285
-
-
Schwedhelm, E.1
Boger, R.H.2
-
27
-
-
70449705942
-
Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion
-
Xia W, Yin Z, Li J, Song Y, Qu X. Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion. Pacing Clin Electrophysiol. 2009;32:1562-1566.
-
(2009)
Pacing Clin Electrophysiol.
, vol.32
, pp. 1562-1566
-
-
Xia, W.1
Yin, Z.2
Li, J.3
Song, Y.4
Qu, X.5
-
28
-
-
84855658119
-
Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation
-
Yang L, Xiufen Q, Shuqin S, Yang Y, Ying S, Yanwei Y et al. Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. J Interv Card Electrophysiol. 2011;32:147-154.
-
(2011)
J Interv Card Electrophysiol.
, vol.32
, pp. 147-154
-
-
Yang, L.1
Xiufen, Q.2
Shuqin, S.3
Yang, Y.4
Ying, S.5
Yanwei, Y.6
-
29
-
-
0032557388
-
Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure
-
Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci. 1998;62:2425-2430.
-
(1998)
Life Sci.
, vol.62
, pp. 2425-2430
-
-
Usui, M.1
Matsuoka, H.2
Miyazaki, H.3
Ueda, S.4
Okuda, S.5
Imaizumi, T.6
-
30
-
-
84861231275
-
Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure
-
Zairis MN, Patsourakos NG, Tsiaousis GZ, Theodossis Georgilas A, Melidonis A, Makrygiannis SS et al. Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure. Heart. 2012;98:860-864.
-
(2012)
Heart
, vol.98
, pp. 860-864
-
-
Zairis, M.N.1
Patsourakos, N.G.2
Tsiaousis, G.Z.3
Theodossis Georgilas, A.4
Melidonis, A.5
Makrygiannis, S.S.6
-
31
-
-
34548188803
-
Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure
-
Duckelmann C, Mittermayer F, Haider DG, Altenberger J, Eichinger J, Wolzt M. Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure. Arterioscl Thromb Vasc Biol. 2007;27:2037-2042.
-
(2007)
Arterioscl Thromb Vasc Biol.
, vol.27
, pp. 2037-2042
-
-
Duckelmann, C.1
Mittermayer, F.2
Haider, D.G.3
Altenberger, J.4
Eichinger, J.5
Wolzt, M.6
-
32
-
-
84861531896
-
Endogenous nitric oxide synthase inhibitors in the biology of disease: Markers, mediators, and regulators?
-
Caplin B, Leiper J. Endogenous nitric oxide synthase inhibitors in the biology of disease: Markers, mediators, and regulators? Arterioscler Thromb Vasc Biol. 2012;32:1343-1353.
-
(2012)
Arterioscler Thromb Vasc Biol.
, vol.32
, pp. 1343-1353
-
-
Caplin, B.1
Leiper, J.2
-
33
-
-
83455230998
-
Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase
-
Von Leitner EC, Klinke A, Atzler D, Slocum JL, Lund N, Kielstein JT et al. Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase. Circulation. 2011;124:2735-2745.
-
(2011)
Circulation
, vol.124
, pp. 2735-2745
-
-
Von Leitner, E.C.1
Klinke, A.2
Atzler, D.3
Slocum, J.L.4
Lund, N.5
Kielstein, J.T.6
-
34
-
-
65949123566
-
Association of plasma asymmetrical dimethylarginine (adma) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: Implications for endothelial function in human atherosclerosis
-
Antoniades C, Shirodaria C, Leeson P, Antonopoulos A, Warrick N, Van-Assche T et al. Association of plasma asymmetrical dimethylarginine (adma) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: Implications for endothelial function in human atherosclerosis. Eur Heart J. 2009;30:1142-1150.
-
(2009)
Eur Heart J
, vol.30
, pp. 1142-1150
-
-
Antoniades, C.1
Shirodaria, C.2
Leeson, P.3
Antonopoulos, A.4
Warrick, N.5
Van-Assche, T.6
-
35
-
-
84885795044
-
Oxidized ca (2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation
-
Purohit A, Rokita AG, Guan X, Chen B, Koval OM, Voigt N et al. Oxidized ca (2+)/calmodulin-dependent protein kinase ii triggers atrial fibrillation. Circulation. 2013;128:1748-1757.
-
(2013)
Circulation
, vol.128
, pp. 1748-1757
-
-
Purohit, A.1
Rokita, A.G.2
Guan, X.3
Chen, B.4
Koval, O.M.5
Voigt, N.6
-
36
-
-
84878725609
-
Oxidative stress in atrial fibrillation: An emerging role of NADPH oxidase
-
Youn JY, Zhang J, Zhang Y, Chen H, Liu D, Ping P et al. Oxidative stress in atrial fibrillation: An emerging role of NADPH oxidase. J Mol Cell Cardiol. 2013;62:72-79.
-
(2013)
J Mol Cell Cardiol.
, vol.62
, pp. 72-79
-
-
Youn, J.Y.1
Zhang, J.2
Zhang, Y.3
Chen, H.4
Liu, D.5
Ping, P.6
-
37
-
-
0037180407
-
Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: Potential mechanisms for atrial thrombosis and stroke
-
Cai H, Li Z, Goette A, Mera F, Honeycutt C, Feterik K, et al. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: Potential mechanisms for atrial thrombosis and stroke. Circulation. 2002;106:2854-2858.
-
(2002)
Circulation
, vol.106
, pp. 2854-2858
-
-
Cai, H.1
Li, Z.2
Goette, A.3
Mera, F.4
Honeycutt, C.5
Feterik, K.6
-
38
-
-
56049112978
-
Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs
-
Liu H, Qu X, Liang Z, Chen W, Xia W, Song Y. Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs. Biochem Biophys Res Commun. 2008;377:884-888.
-
(2008)
Biochem Biophys Res Commun
, vol.377
, pp. 884-888
-
-
Liu, H.1
Qu, X.2
Liang, Z.3
Chen, W.4
Xia, W.5
Song, Y.6
-
39
-
-
54149088882
-
Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure
-
Wilson Tang WH, Tong W, Shrestha K, Wang Z, Levison BS, Delfraino B et al. Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure. Eur Heart J. 2008;29:2506-2513.
-
(2008)
Eur Heart J
, vol.29
, pp. 2506-2513
-
-
Wilson Tang, W.H.1
Tong, W.2
Shrestha, K.3
Wang, Z.4
Levison, B.S.5
Delfraino, B.6
|